ID   L1210/VMDRC.06
AC   CVCL_C8R8
DR   Wikidata; Q123032881
RX   PubMed=8094615;
RX   PubMed=15294454;
CC   Transfected with: HGNC; 40; ABCB1.
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0382 ! L1210
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=8094615; DOI=10.1016/0006-2952(93)90076-9;
RA   Hait W.N., Gesmonde J.F., Murren J.R., Yang J.-M., Chen H.-X., Reiss M.;
RT   "Terfenadine (Seldane): a new drug for restoring sensitivity to
RT   multidrug resistant cancer cells.";
RL   Biochem. Pharmacol. 45:401-406(1993).
//
RX   PubMed=15294454; DOI=10.1016/j.bcp.2004.06.004;
RA   Zeng H., Lin Z.P., Sartorelli A.C.;
RT   "Resistance to purine and pyrimidine nucleoside and nucleobase analogs
RT   by the human MDR1 transfected murine leukemia cell line
RT   L1210/VMDRC.06.";
RL   Biochem. Pharmacol. 68:911-921(2004).
//